Leadership Overview
AbbVie has 10 executives leading key functions including financial integration, immunology strategy, clinical operations, regional finance, information technology, marketing, neuroscience research, healthcare delivery, and revenue management.
Driven by a commitment to medical innovation, AbbVie advances global health through the development of specialized therapies for complex diseases, ensuring patients receive transformative care across diverse therapeutic landscapes.
Driven by a commitment to medical innovation, AbbVie advances global health through the development of specialized therapies for complex diseases, ensuring patients receive transformative care across diverse therapeutic landscapes.
Leadership Roles at AbbVie
Jennifer Davis - Chief Executive Officer, Health Care
Jennifer Davis, the Chief Executive Officer, Health Care at AbbVie, directs the overarching strategy for the company's healthcare delivery and patient access initiatives. Davis architects programs that ensure patients receive timely access to life-altering medicines. By collaborating with healthcare systems and policy stakeholders, the Chief Executive Officer, Health Care strengthens the company's impact on patient outcomes. This role involves overseeing the commercial and operational strategies that support the delivery of health solutions across diverse global markets. Jennifer Davis monitors the performance of healthcare-focused business units, ensuring that all activities align with the company's mission to address complex medical challenges. Through the leadership of healthcare initiatives, the Chief Executive Officer, Health Care drives the company's commitment to improving the quality of life for patients, ensuring that innovative therapies reach those who need them most.
Hasan Kurt - Chief Financial Officer, Integration Lead Allergan Aesthetics
Hasan Kurt, the Chief Financial Officer, Integration Lead Allergan Aesthetics at AbbVie, manages the fiscal architecture supporting the medical aesthetics portfolio. Kurt directs the financial consolidation processes required to maintain operational synergy following the Allergan acquisition. By overseeing capital allocation and budgetary frameworks, the Chief Financial Officer, Integration Lead Allergan Aesthetics ensures that resources align with long-term growth objectives in the aesthetics market. This role involves rigorous analysis of market trends to optimize profitability across international business units. Hasan Kurt maintains oversight of financial reporting standards, providing the executive board with actionable data regarding asset performance. Through disciplined fiscal management, the Chief Financial Officer, Integration Lead Allergan Aesthetics strengthens the competitive position of the company, enabling sustained investment in innovative health solutions that address significant unmet medical needs globally.
Jeanne Martinez - Regional Chief Financial Officer
Jeanne Martinez, the Regional Chief Financial Officer at AbbVie, manages the financial health of operations across key international markets. Martinez directs regional budgetary planning and fiscal compliance, ensuring that local business units adhere to global corporate standards. By analyzing economic indicators and market volatility, the Regional Chief Financial Officer provides the necessary insights to mitigate financial risk in diverse geographic territories. This role involves coordinating with local leadership to optimize cost structures and improve operational margins. Jeanne Martinez oversees the allocation of regional resources to support the commercialization of the company's pharmaceutical portfolio. Through strategic financial oversight, the Regional Chief Financial Officer strengthens the company's presence in international markets, ensuring that regional performance contributes effectively to the overall growth and stability of the global biopharmaceutical enterprise.
Anjili Mathur - Chief of Staff I Director II, Immunology Strategic Management
Anjili Mathur, the Chief of Staff I Director II, Immunology Strategic Management at AbbVie, architects the operational roadmap for the immunology division. Mathur coordinates cross-functional teams to accelerate the development of therapies targeting chronic inflammatory conditions. By streamlining internal communication and project workflows, the Chief of Staff I Director II, Immunology Strategic Management ensures that scientific research translates efficiently into commercial success. This leadership position requires constant collaboration with clinical leads to refine strategic priorities and resource distribution. Anjili Mathur monitors the progress of key immunology assets, identifying potential bottlenecks in the development pipeline. Through meticulous management of strategic initiatives, the Chief of Staff I Director II, Immunology Strategic Management supports the broader mission of improving patient outcomes, ultimately driving the company toward market leadership in the complex field of immunology.
Brian Szopinski - Director, Clinical Operations & Chief of Staff
Brian Szopinski, the Director, Clinical Operations & Chief of Staff at AbbVie, oversees the execution of complex clinical trials across the global portfolio. Szopinski directs the operational infrastructure necessary to maintain compliance and data integrity throughout the drug development lifecycle. By managing the interface between clinical research teams and executive leadership, the Director, Clinical Operations & Chief of Staff ensures that trial milestones align with corporate timelines. This role involves optimizing site selection and patient recruitment strategies to enhance the speed of therapeutic delivery. Brian Szopinski monitors performance metrics to identify efficiencies in clinical workflows, reducing time-to-market for critical medicines. Through rigorous oversight of operational standards, the Director, Clinical Operations & Chief of Staff facilitates the advancement of the company's pipeline, ensuring that scientific breakthroughs reach patients suffering from serious, life-altering diseases.
Prateek Panigrahi - Chief of Staff & Director, Clinical Operations
Prateek Panigrahi, the Chief of Staff & Director, Clinical Operations at AbbVie, manages the strategic alignment of clinical development programs. Panigrahi directs the operational planning for late-stage trials, ensuring that resources support the most promising therapeutic candidates. By facilitating communication between clinical teams and the executive suite, the Chief of Staff & Director, Clinical Operations ensures that development goals remain synchronized with the company's long-term scientific vision. This role involves identifying process improvements to enhance the quality and speed of clinical data collection. Prateek Panigrahi monitors the progress of ongoing studies, providing the necessary support to overcome operational challenges. Through the management of clinical operations, the Chief of Staff & Director, Clinical Operations enables the company to deliver innovative medicines that address complex medical challenges, ultimately improving the quality of life for patients worldwide.
Linda Ray - Senior VP & Chief Information Officer
Linda Ray, the Senior VP & Chief Information Officer at AbbVie, directs the digital transformation and technological infrastructure of the organization. Ray architects secure data systems that support global research, development, and commercial operations. By implementing advanced analytics and cloud-based solutions, the Senior VP & Chief Information Officer enhances the company's ability to process complex medical data. This role involves overseeing cybersecurity protocols to protect intellectual property and patient information across all international sites. Linda Ray collaborates with other C-suite leaders to integrate technology into the core business model, driving efficiency in drug discovery and supply chain management. Through the deployment of cutting-edge digital tools, the Senior VP & Chief Information Officer ensures that the company maintains a competitive edge in the biopharmaceutical industry, facilitating the rapid delivery of health solutions to patients in need.
Carla Stalfa - Chief Marketing Officer & Trial Management Analyst
Carla Stalfa, the Chief Marketing Officer & Trial Management Analyst at AbbVie, directs the commercial strategy and market positioning for the company's therapeutic portfolio. Stalfa analyzes clinical trial data to develop evidence-based marketing campaigns that highlight the efficacy of new medicines. By bridging the gap between clinical research and commercial outreach, the Chief Marketing Officer & Trial Management Analyst ensures that healthcare providers understand the value of the company's innovations. This role involves monitoring market trends and patient needs to refine promotional strategies across various therapeutic areas. Carla Stalfa oversees the development of educational materials that support the adoption of new treatments. Through the integration of trial insights into marketing initiatives, the Chief Marketing Officer & Trial Management Analyst drives the successful launch and sustained growth of the company's products in the global marketplace.
Martin Hayes - Global Neuroscience & Ophthalmology Research Chief of Staff
Martin Hayes, the Global Neuroscience & Ophthalmology Research Chief of Staff at AbbVie, coordinates the strategic research efforts within the neuroscience and eye care divisions. Hayes directs the operational planning for early-stage discovery projects, ensuring that scientific teams focus on high-impact therapeutic targets. By managing the interface between research labs and clinical development, the Global Neuroscience & Ophthalmology Research Chief of Staff accelerates the transition of new compounds through the pipeline. This role involves aligning research priorities with the company's long-term goals in neuroscience and ophthalmology. Martin Hayes monitors the progress of key research initiatives, providing the necessary support to overcome technical hurdles. Through the management of research operations, the Global Neuroscience & Ophthalmology Research Chief of Staff facilitates the creation of innovative therapies that address significant unmet medical needs in the fields of brain health and vision.
Nancy Radcliffe - Senior Coordinator - Chief Revenue Officer and Trade Accounts
Nancy Radcliffe, the Senior Coordinator - Chief Revenue Officer and Trade Accounts at AbbVie, manages the operational workflows supporting revenue generation and trade account management. Radcliffe directs the coordination between sales teams and trade partners to ensure the efficient distribution of the company's pharmaceutical products. By overseeing the administrative processes that underpin revenue cycles, the Senior Coordinator - Chief Revenue Officer and Trade Accounts ensures that commercial operations remain seamless and compliant. This role involves monitoring trade account performance and identifying opportunities to optimize supply chain interactions. Nancy Radcliffe collaborates with the revenue leadership team to implement strategies that maximize market reach and financial performance. Through the management of trade accounts and revenue-related coordination, the Senior Coordinator - Chief Revenue Officer and Trade Accounts supports the company's ability to deliver innovative medicines to patients on a global scale.
Explore Leadership Teams in Manufacturing
Since 2006, Pharos Indonesia has been the fastest growing pharmaceutical company in Indonesia, achieving 40% annual growth. In 2009, based on IMS* reports, Pharos became the 4th largest Indonesian pharmaceutical company; jumping from position 12 in just 4 years. Pharos marketing teams have forged strong relationships with major hospital groups as well as individual doctors, including specialists and this ensures strong distribution of our products. No other pharmaceutical manufacturer, nor retail pharmacy group, can compete with the strength of the Pharos-controlled network of almost 2,000 pharmacies spread across Indonesia. Pharos is uniquely positioned to take advantage of the large and fast-growing ASEAN region.
Company Leadership VP
HD
AL
RR
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
KW
FC
Founded in 1987, Integrated DNA Technologies, Inc. headquartered in Coralville, Iowa, is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. The company develops, manufactures, and markets nucleic acid products for the life sciences industry.
Company Leadership AA
MM
AM
CL
Formosa Laboratories, Inc. produces APIs and UV-filters in its modern facilities near Taipei. Its GMP compliance has been approved by DOH of Taiwan, US FDA, BGV of Germany, EDQM and PMDA of Japan. Formosas major API products include Vitamin D derivatives (Alfacalcidol, Calcitriol, Calcipotriol, Doxercalciferol, and Paricalcitol), Balsalazide, Benzonatate, Capsaicin, Colesevelam, Gadodiamide, Flupentixol, Melitracen, Meprobamate, Montelukast, Mycophenolate Mofetil, Sevelamer (HCl and Carbonate), and Taltirelin. As a major producer in the world, the company's UV-filter products include avobenzone and Octinoxate. The company also provide custom synthesis service from process development to full commercial production for APIs and other specialty chemicals, with full documentation support.
Company Leadership CY
CC
CC
CY
Frequently Asked Questions Regarding AbbVie Top Executives and Leadership Team
Unlock more people and company data
